Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer
Studies evaluating enhancer of zeste homolog 2 (EZH2) expression and oncologic outcomes in bladder cancer have been discrepant. EZH2 expression in noninvasive bladder cancer is not well studied. We thus set out to address the discrepancy in previous reports, and to study expression of EZH2 in noninv...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Warrick, Joshua I. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
6 |
|---|
| Übergeordnetes Werk: |
Enthalten in: BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex - Siero, Jeroen C.W. ELSEVIER, 2014transfer abstract, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:34 ; year:2016 ; number:6 ; pages:2581-2586 ; extent:6 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.urolonc.2016.02.011 |
|---|
| Katalog-ID: |
ELV029975190 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV029975190 | ||
| 003 | DE-627 | ||
| 005 | 20230623203247.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.urolonc.2016.02.011 |2 doi | |
| 028 | 5 | 2 | |a GBVA2016018000010.pica |
| 035 | |a (DE-627)ELV029975190 | ||
| 035 | |a (ELSEVIER)S1078-1439(16)00044-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 100 | 1 | |a Warrick, Joshua I. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer |
| 264 | 1 | |c 2016 | |
| 300 | |a 6 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Studies evaluating enhancer of zeste homolog 2 (EZH2) expression and oncologic outcomes in bladder cancer have been discrepant. EZH2 expression in noninvasive bladder cancer is not well studied. We thus set out to address the discrepancy in previous reports, and to study expression of EZH2 in noninvasive bladder cancer and its associations, in a large cystectomy cohort. | ||
| 650 | 7 | |a Urothelial carcinoma in situ |2 Elsevier | |
| 650 | 7 | |a Tumor lineage |2 Elsevier | |
| 650 | 7 | |a Papillary urothelial carcinoma |2 Elsevier | |
| 650 | 7 | |a Bladder cancer |2 Elsevier | |
| 650 | 7 | |a EZH2 |2 Elsevier | |
| 650 | 7 | |a Urothelium |2 Elsevier | |
| 700 | 1 | |a Raman, Jay D. |4 oth | |
| 700 | 1 | |a Kaag, Matthew |4 oth | |
| 700 | 1 | |a Bruggeman, Trey |4 oth | |
| 700 | 1 | |a Cates, Justin |4 oth | |
| 700 | 1 | |a Clark, Peter |4 oth | |
| 700 | 1 | |a DeGraff, David J. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Siero, Jeroen C.W. ELSEVIER |t BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex |d 2014transfer abstract |g Amsterdam [u.a.] |w (DE-627)ELV012523860 |
| 773 | 1 | 8 | |g volume:34 |g year:2016 |g number:6 |g pages:2581-2586 |g extent:6 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.urolonc.2016.02.011 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 951 | |a AR | ||
| 952 | |d 34 |j 2016 |e 6 |h 2581-2586 |g 6 |y 34.2016, 6, 258.e1-, (6 S.) | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
j i w ji jiw |
|---|---|
| matchkey_str |
warrickjoshuairamanjaydkaagmatthewbrugge:2016----:nacrfethmlgehepesoi |
| hierarchy_sort_str |
2016 |
| publishDate |
2016 |
| allfields |
10.1016/j.urolonc.2016.02.011 doi GBVA2016018000010.pica (DE-627)ELV029975190 (ELSEVIER)S1078-1439(16)00044-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ Warrick, Joshua I. verfasserin aut Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer 2016 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Studies evaluating enhancer of zeste homolog 2 (EZH2) expression and oncologic outcomes in bladder cancer have been discrepant. EZH2 expression in noninvasive bladder cancer is not well studied. We thus set out to address the discrepancy in previous reports, and to study expression of EZH2 in noninvasive bladder cancer and its associations, in a large cystectomy cohort. Urothelial carcinoma in situ Elsevier Tumor lineage Elsevier Papillary urothelial carcinoma Elsevier Bladder cancer Elsevier EZH2 Elsevier Urothelium Elsevier Raman, Jay D. oth Kaag, Matthew oth Bruggeman, Trey oth Cates, Justin oth Clark, Peter oth DeGraff, David J. oth Enthalten in Elsevier Science Siero, Jeroen C.W. ELSEVIER BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex 2014transfer abstract Amsterdam [u.a.] (DE-627)ELV012523860 volume:34 year:2016 number:6 pages:2581-2586 extent:6 https://doi.org/10.1016/j.urolonc.2016.02.011 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 34 2016 6 2581-2586 6 34.2016, 6, 258.e1-, (6 S.) 045F 610 |
| spelling |
10.1016/j.urolonc.2016.02.011 doi GBVA2016018000010.pica (DE-627)ELV029975190 (ELSEVIER)S1078-1439(16)00044-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ Warrick, Joshua I. verfasserin aut Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer 2016 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Studies evaluating enhancer of zeste homolog 2 (EZH2) expression and oncologic outcomes in bladder cancer have been discrepant. EZH2 expression in noninvasive bladder cancer is not well studied. We thus set out to address the discrepancy in previous reports, and to study expression of EZH2 in noninvasive bladder cancer and its associations, in a large cystectomy cohort. Urothelial carcinoma in situ Elsevier Tumor lineage Elsevier Papillary urothelial carcinoma Elsevier Bladder cancer Elsevier EZH2 Elsevier Urothelium Elsevier Raman, Jay D. oth Kaag, Matthew oth Bruggeman, Trey oth Cates, Justin oth Clark, Peter oth DeGraff, David J. oth Enthalten in Elsevier Science Siero, Jeroen C.W. ELSEVIER BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex 2014transfer abstract Amsterdam [u.a.] (DE-627)ELV012523860 volume:34 year:2016 number:6 pages:2581-2586 extent:6 https://doi.org/10.1016/j.urolonc.2016.02.011 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 34 2016 6 2581-2586 6 34.2016, 6, 258.e1-, (6 S.) 045F 610 |
| allfields_unstemmed |
10.1016/j.urolonc.2016.02.011 doi GBVA2016018000010.pica (DE-627)ELV029975190 (ELSEVIER)S1078-1439(16)00044-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ Warrick, Joshua I. verfasserin aut Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer 2016 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Studies evaluating enhancer of zeste homolog 2 (EZH2) expression and oncologic outcomes in bladder cancer have been discrepant. EZH2 expression in noninvasive bladder cancer is not well studied. We thus set out to address the discrepancy in previous reports, and to study expression of EZH2 in noninvasive bladder cancer and its associations, in a large cystectomy cohort. Urothelial carcinoma in situ Elsevier Tumor lineage Elsevier Papillary urothelial carcinoma Elsevier Bladder cancer Elsevier EZH2 Elsevier Urothelium Elsevier Raman, Jay D. oth Kaag, Matthew oth Bruggeman, Trey oth Cates, Justin oth Clark, Peter oth DeGraff, David J. oth Enthalten in Elsevier Science Siero, Jeroen C.W. ELSEVIER BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex 2014transfer abstract Amsterdam [u.a.] (DE-627)ELV012523860 volume:34 year:2016 number:6 pages:2581-2586 extent:6 https://doi.org/10.1016/j.urolonc.2016.02.011 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 34 2016 6 2581-2586 6 34.2016, 6, 258.e1-, (6 S.) 045F 610 |
| allfieldsGer |
10.1016/j.urolonc.2016.02.011 doi GBVA2016018000010.pica (DE-627)ELV029975190 (ELSEVIER)S1078-1439(16)00044-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ Warrick, Joshua I. verfasserin aut Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer 2016 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Studies evaluating enhancer of zeste homolog 2 (EZH2) expression and oncologic outcomes in bladder cancer have been discrepant. EZH2 expression in noninvasive bladder cancer is not well studied. We thus set out to address the discrepancy in previous reports, and to study expression of EZH2 in noninvasive bladder cancer and its associations, in a large cystectomy cohort. Urothelial carcinoma in situ Elsevier Tumor lineage Elsevier Papillary urothelial carcinoma Elsevier Bladder cancer Elsevier EZH2 Elsevier Urothelium Elsevier Raman, Jay D. oth Kaag, Matthew oth Bruggeman, Trey oth Cates, Justin oth Clark, Peter oth DeGraff, David J. oth Enthalten in Elsevier Science Siero, Jeroen C.W. ELSEVIER BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex 2014transfer abstract Amsterdam [u.a.] (DE-627)ELV012523860 volume:34 year:2016 number:6 pages:2581-2586 extent:6 https://doi.org/10.1016/j.urolonc.2016.02.011 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 34 2016 6 2581-2586 6 34.2016, 6, 258.e1-, (6 S.) 045F 610 |
| allfieldsSound |
10.1016/j.urolonc.2016.02.011 doi GBVA2016018000010.pica (DE-627)ELV029975190 (ELSEVIER)S1078-1439(16)00044-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ Warrick, Joshua I. verfasserin aut Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer 2016 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Studies evaluating enhancer of zeste homolog 2 (EZH2) expression and oncologic outcomes in bladder cancer have been discrepant. EZH2 expression in noninvasive bladder cancer is not well studied. We thus set out to address the discrepancy in previous reports, and to study expression of EZH2 in noninvasive bladder cancer and its associations, in a large cystectomy cohort. Urothelial carcinoma in situ Elsevier Tumor lineage Elsevier Papillary urothelial carcinoma Elsevier Bladder cancer Elsevier EZH2 Elsevier Urothelium Elsevier Raman, Jay D. oth Kaag, Matthew oth Bruggeman, Trey oth Cates, Justin oth Clark, Peter oth DeGraff, David J. oth Enthalten in Elsevier Science Siero, Jeroen C.W. ELSEVIER BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex 2014transfer abstract Amsterdam [u.a.] (DE-627)ELV012523860 volume:34 year:2016 number:6 pages:2581-2586 extent:6 https://doi.org/10.1016/j.urolonc.2016.02.011 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 34 2016 6 2581-2586 6 34.2016, 6, 258.e1-, (6 S.) 045F 610 |
| language |
English |
| source |
Enthalten in BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex Amsterdam [u.a.] volume:34 year:2016 number:6 pages:2581-2586 extent:6 |
| sourceStr |
Enthalten in BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex Amsterdam [u.a.] volume:34 year:2016 number:6 pages:2581-2586 extent:6 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Urothelial carcinoma in situ Tumor lineage Papillary urothelial carcinoma Bladder cancer EZH2 Urothelium |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex |
| authorswithroles_txt_mv |
Warrick, Joshua I. @@aut@@ Raman, Jay D. @@oth@@ Kaag, Matthew @@oth@@ Bruggeman, Trey @@oth@@ Cates, Justin @@oth@@ Clark, Peter @@oth@@ DeGraff, David J. @@oth@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV012523860 |
| dewey-sort |
3610 |
| id |
ELV029975190 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV029975190</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623203247.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.urolonc.2016.02.011</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016018000010.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV029975190</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1078-1439(16)00044-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Warrick, Joshua I.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Studies evaluating enhancer of zeste homolog 2 (EZH2) expression and oncologic outcomes in bladder cancer have been discrepant. EZH2 expression in noninvasive bladder cancer is not well studied. We thus set out to address the discrepancy in previous reports, and to study expression of EZH2 in noninvasive bladder cancer and its associations, in a large cystectomy cohort.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Urothelial carcinoma in situ</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tumor lineage</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Papillary urothelial carcinoma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bladder cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EZH2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Urothelium</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Raman, Jay D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kaag, Matthew</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bruggeman, Trey</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cates, Justin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Clark, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">DeGraff, David J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Siero, Jeroen C.W. ELSEVIER</subfield><subfield code="t">BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex</subfield><subfield code="d">2014transfer abstract</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV012523860</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:34</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:6</subfield><subfield code="g">pages:2581-2586</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.urolonc.2016.02.011</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">34</subfield><subfield code="j">2016</subfield><subfield code="e">6</subfield><subfield code="h">2581-2586</subfield><subfield code="g">6</subfield><subfield code="y">34.2016, 6, 258.e1-, (6 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Warrick, Joshua I. |
| spellingShingle |
Warrick, Joshua I. ddc 610 Elsevier Urothelial carcinoma in situ Elsevier Tumor lineage Elsevier Papillary urothelial carcinoma Elsevier Bladder cancer Elsevier EZH2 Elsevier Urothelium Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer |
| authorStr |
Warrick, Joshua I. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV012523860 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer Urothelial carcinoma in situ Elsevier Tumor lineage Elsevier Papillary urothelial carcinoma Elsevier Bladder cancer Elsevier EZH2 Elsevier Urothelium Elsevier |
| topic |
ddc 610 Elsevier Urothelial carcinoma in situ Elsevier Tumor lineage Elsevier Papillary urothelial carcinoma Elsevier Bladder cancer Elsevier EZH2 Elsevier Urothelium |
| topic_unstemmed |
ddc 610 Elsevier Urothelial carcinoma in situ Elsevier Tumor lineage Elsevier Papillary urothelial carcinoma Elsevier Bladder cancer Elsevier EZH2 Elsevier Urothelium |
| topic_browse |
ddc 610 Elsevier Urothelial carcinoma in situ Elsevier Tumor lineage Elsevier Papillary urothelial carcinoma Elsevier Bladder cancer Elsevier EZH2 Elsevier Urothelium |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
j d r jd jdr m k mk t b tb j c jc p c pc d j d dj djd |
| hierarchy_parent_title |
BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex |
| hierarchy_parent_id |
ELV012523860 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV012523860 |
| title |
Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer |
| ctrlnum |
(DE-627)ELV029975190 (ELSEVIER)S1078-1439(16)00044-2 |
| title_full |
Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer |
| author_sort |
Warrick, Joshua I. |
| journal |
BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex |
| journalStr |
BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
2581 |
| author_browse |
Warrick, Joshua I. |
| container_volume |
34 |
| physical |
6 |
| class |
610 610 DE-600 610 VZ |
| format_se |
Elektronische Aufsätze |
| author-letter |
Warrick, Joshua I. |
| doi_str_mv |
10.1016/j.urolonc.2016.02.011 |
| dewey-full |
610 |
| title_sort |
enhancer of zeste homolog 2 (ezh2) expression in bladder cancer |
| title_auth |
Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer |
| abstract |
Studies evaluating enhancer of zeste homolog 2 (EZH2) expression and oncologic outcomes in bladder cancer have been discrepant. EZH2 expression in noninvasive bladder cancer is not well studied. We thus set out to address the discrepancy in previous reports, and to study expression of EZH2 in noninvasive bladder cancer and its associations, in a large cystectomy cohort. |
| abstractGer |
Studies evaluating enhancer of zeste homolog 2 (EZH2) expression and oncologic outcomes in bladder cancer have been discrepant. EZH2 expression in noninvasive bladder cancer is not well studied. We thus set out to address the discrepancy in previous reports, and to study expression of EZH2 in noninvasive bladder cancer and its associations, in a large cystectomy cohort. |
| abstract_unstemmed |
Studies evaluating enhancer of zeste homolog 2 (EZH2) expression and oncologic outcomes in bladder cancer have been discrepant. EZH2 expression in noninvasive bladder cancer is not well studied. We thus set out to address the discrepancy in previous reports, and to study expression of EZH2 in noninvasive bladder cancer and its associations, in a large cystectomy cohort. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| container_issue |
6 |
| title_short |
Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer |
| url |
https://doi.org/10.1016/j.urolonc.2016.02.011 |
| remote_bool |
true |
| author2 |
Raman, Jay D. Kaag, Matthew Bruggeman, Trey Cates, Justin Clark, Peter DeGraff, David J. |
| author2Str |
Raman, Jay D. Kaag, Matthew Bruggeman, Trey Cates, Justin Clark, Peter DeGraff, David J. |
| ppnlink |
ELV012523860 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth |
| doi_str |
10.1016/j.urolonc.2016.02.011 |
| up_date |
2024-07-06T22:52:02.141Z |
| _version_ |
1803871922047418368 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV029975190</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623203247.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.urolonc.2016.02.011</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016018000010.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV029975190</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1078-1439(16)00044-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Warrick, Joshua I.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Studies evaluating enhancer of zeste homolog 2 (EZH2) expression and oncologic outcomes in bladder cancer have been discrepant. EZH2 expression in noninvasive bladder cancer is not well studied. We thus set out to address the discrepancy in previous reports, and to study expression of EZH2 in noninvasive bladder cancer and its associations, in a large cystectomy cohort.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Urothelial carcinoma in situ</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tumor lineage</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Papillary urothelial carcinoma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bladder cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EZH2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Urothelium</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Raman, Jay D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kaag, Matthew</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bruggeman, Trey</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cates, Justin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Clark, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">DeGraff, David J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Siero, Jeroen C.W. ELSEVIER</subfield><subfield code="t">BOLD matches neuronal activity at the mm scale: A combined 7T fMRI and ECoG study in human sensorimotor cortex</subfield><subfield code="d">2014transfer abstract</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV012523860</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:34</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:6</subfield><subfield code="g">pages:2581-2586</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.urolonc.2016.02.011</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">34</subfield><subfield code="j">2016</subfield><subfield code="e">6</subfield><subfield code="h">2581-2586</subfield><subfield code="g">6</subfield><subfield code="y">34.2016, 6, 258.e1-, (6 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.3989124 |